Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
British Journal of Clinical Pharmacology|February 3, 2018
The pharmacodynamic and clinical trial evidence for statin doseSimon B Dimmitt, Hans G Stampfer, John B WarrenBritish Journal of Clinical Pharmacology|June 11, 2014
β-adrenoceptor blockers valuable but higher doses not necessarySimon B Dimmitt, Hans G Stampfer, John B WarrenBritish Journal of Clinical Pharmacology|April 5, 2016
Cholesterol trials and mortalityJohn B Warren, Simon B Dimmitt, Hans G StampferThe Medical Journal of Australia|November 4, 2009
Low drug doses may improve outcomes in chronic diseaseSimon B Dimmitt, Hans G StampferBritish Journal of Clinical Pharmacology|June 21, 2019
Why maximum tolerated dose?Hans G Stampfer, Genevieve M Gabb, Simon B DimmittBritish Journal of Clinical Pharmacology|June 21, 2019
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50Simon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.Pharmacology Research & Perspectives|December 16, 2025
Rethinking Statin Dosage in Coronary DiseaseSimon B Dimmitt, Hans G Stampfer, Michael C Kennedy, et al.Annals of the Royal Australasian College of Dental Surgeons|November 4, 2011
General well-being in the new decade--important considerationsSimon B DimmittExpert Opinion on Pharmacotherapy|January 26, 2016
Sitagliptin and other 'gliptins'--why prescribe them?Sheila A Doggrell, Simon B DimmittExpert Opinion on Pharmacotherapy|January 24, 2017
Lipid and other management to improve arterial disease and survival in end stage renal diseaseSimon B Dimmitt, Jennifer H MartinPageof 3